Are pancreatic autoantibodies associated with azathioprine-induced pancreatitis in Crohn's disease?
暂无分享,去创建一个
[1] I. Nolte,et al. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases , 2007, Scandinavian journal of gastroenterology.
[2] E. Kouroumalis,et al. Pancreatic Autoantibodies in Greek Patients with Inflammatory Bowel Disease , 2005, Digestive Diseases and Sciences.
[3] S. Targan,et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. , 2005, Gastroenterology.
[4] K. Saeian,et al. Increased Rates of Early Adverse Reaction to Azathioprine in Patients with Crohn's Disease Compared to Autoimmune Hepatitis: A Tertiary Referral Center Experience , 2005, The American Journal of Gastroenterology.
[5] C. Libersa,et al. ITPA genotyping test does not improve detection of Crohn’s disease patients at risk of azathioprine/6-mercaptopurine induced myelosuppression , 2005, Gut.
[6] F. Klebl,et al. Association of antibodies to exocrine pancreas with subtypes of Crohn’s disease , 2005, European journal of gastroenterology & hepatology.
[7] J. Colombel,et al. Relevance of serologic studies in inflammatory bowel disease , 2004, Current gastroenterology reports.
[8] K. Van Steen,et al. Pancreatic Autoantibodies in Inflammatory Bowel Disease , 2004, Inflammatory bowel diseases.
[9] R. Gearry,et al. Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine. , 2004, Pharmacogenetics.
[10] J. J. Homan van der Heide,et al. Increased incidence of azathioprine‐induced pancreatitis in Crohn's disease compared with other diseases , 2004, Alimentary pharmacology & therapeutics.
[11] C. Lewis,et al. Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase). , 2004, Pharmacogenetics.
[12] D. Podolsky,et al. Inflammatory bowel disease. , 2002, The New England journal of medicine.
[13] K. Decochez,et al. Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies. , 2001, Diabetes care.
[14] S. Targan,et al. Colonic Bacteria Express an Ulcerative Colitis pANCA-Related Protein Epitope , 2000, Infection and Immunity.
[15] P. Bingley,et al. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. , 1998, Diabetes.
[16] S. Targan,et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role , 1998, Gut.
[17] H. Buhr,et al. Effect of different immunosuppressive agents on acute pancreatitis: a comparative study in an improved animal model. , 1998, Transplantation.
[18] S. Endres,et al. Antineutrophil and pancreatic autoantibodies in first-degree relatives of patients with inflammatory bowel disease. , 1998, Scandinavian journal of gastroenterology.
[19] William D. Dupont,et al. PS power and sample size program available for free on the internet , 1997 .
[20] M. Relling,et al. Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms. , 1996, Pharmacogenetics.
[21] M. Scheurlen,et al. Impaired pancreatic function in patients with Crohn's disease with and without pancreatic autoantibodies. , 1996, Journal of clinical gastroenterology.
[22] F. Seibold,et al. Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patients with Crohn's disease. , 1991, Gut.
[23] M. Otte,et al. [Autoantibodies against the exocrine pancreas and against intestinal goblet cells in the diagnosis of Crohn's disease and ulcerative colitis]. , 2008, Deutsche medizinische Wochenschrift.